SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-20-058469
Filing Date
2020-05-08
Accepted
2020-05-08 09:57:11
Documents
2
Group Members
ALEC N. LITOWITZMAGNETAR CAPITAL PARTNERS LPSUPERNOVA MANAGEMENT LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D a20-19052_1sc13d.htm SC 13D 136730
2 EX-99.1 a20-19052_1ex99d1.htm EX-99.1 16935
  Complete submission text file 0001104659-20-058469.txt   155302
Mailing Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080
Business Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080 650-244-6864
PORTOLA PHARMACEUTICALS INC (Subject) CIK: 0001269021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87472 | Film No.: 20859085
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1603 ORRINGTON AVE. 13TH FLOOR EVANSTON IL 60201
Business Address 1603 ORRINGTON AVE. 13TH FLOOR EVANSTON IL 60201 (847)905-4400
Magnetar Financial LLC (Filed by) CIK: 0001352851 (see all company filings)

IRS No.: 043818748 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D